Allergen Immunotherapy (AIT): a prototype of Precision Medicine

Paving the way for personalizdd medicine, FDA’s role in a new era of medical product development. http://www.fdagov/downloads/ScienceResearch/SpecialTopics/PersonalizedMedicine/UCM372421pdf. 2013 Hamburg, 2010, The path to personalized medicine, N Engl J Med, 363, 301, 10.1056/NEJMp1006304 Bousquet, 2014, Systems medicine approaches for the definition of complex phenotypes in chronic diseases and ageing. From concept to implementation and policies, Curr Pharm Des, 20, 5928, 10.2174/1381612820666140314115505 Ramsey, 2011, A CFTR potentiator in patients with cystic fibrosis and the G551D mutation, N Engl J Med, 365, 1663, 10.1056/NEJMoa1105185 Collins, 2015, A new initiative on precision medicine, N Engl J Med, 372, 793, 10.1056/NEJMp1500523 Braido, 2012, From "blockbusters" to "biosimilars": an opportunity for patients, medical specialists and health care providers, Pulm Pharmacol Ther, 25, 483, 10.1016/j.pupt.2012.09.005 Vieths, 2013, Personalised medicine for the diagnosis and treatment of allergic diseases, Bundesgesundheitsblatt, Gesundheitsforschung, Gesundheitsschutz, 56, 1531, 10.1007/s00103-013-1821-3 Bousquet, 2014, Integrated care pathways for airway diseases (AIRWAYS-ICPs), Eur Respir J, 44, 304, 10.1183/09031936.00014614 Bousquet, 2014, MACVIA-LR Reference Site of the European Innovation Partnership on Active and Healthy Ageing, Eur Geriatr Med, 5, 406, 10.1016/j.eurger.2014.07.013 Bousquet, 2009, GA2LEN skin test study III: minimum battery of test inhalent allergens needed in epidemiological studies in patients, Allergy, 64, 1656, 10.1111/j.1398-9995.2009.02169.x Canonica, 2013, A WAO - ARIA - GA(2)LEN consensus document on molecular-based allergy diagnostics, World Allergy Organ J, 6, 17, 10.1186/1939-4551-6-17 Incorvaia C, Mauro M, Ridolo E, Makri E, Montagni M, Ciprandi G. A Pitfall to Avoid When Using an Allergen Microarray: The Incidental Detection of IgE to Unexpected Allergens. J Allergy Clin Immunol Pract. 2014. doi:10.1016/j.jaip.2014.09.020. Barber, 2015, Challenges for allergy diagnosis in regions with complex pollen exposures, Curr Allergy Asthma Rep, 15, 496, 10.1007/s11882-014-0496-7 Stringari, 2014, The effect of component-resolved diagnosis on specific immunotherapy prescription in children with hay fever, J Allergy Clin Immunol, 134, 75, 10.1016/j.jaci.2014.01.042 Vallier, 1995, Identification of profilin as an IgE-binding component in latex from Hevea brasiliensis: clinical implications, Clin Exp Allergy, 25, 332, 10.1111/j.1365-2222.1995.tb01051.x Holzweber, 2013, Inhibition of IgE binding to cross-reactive carbohydrate determinants enhances diagnostic selectivity, Allergy, 68, 1269, 10.1111/all.12229 Lupinek, 2014, Advances in allergen-microarray technology for diagnosis and monitoring of allergy: the MeDALL allergen-chip, Methods, 66, 106, 10.1016/j.ymeth.2013.10.008 Flicker, 2003, Renaissance of the blocking antibody concept in type I allergy, Int Arch Allergy Immunol, 132, 13, 10.1159/000073260 Matsuoka, 2013, Allergen immunotherapy and tolerance, Allergol Int, 62, 403, 10.2332/allergolint.13-RAI-0650 Akdis, 2014, Mechanisms of immune tolerance to allergens: role of IL-10 and Tregs, J Clin Invest, 124, 4678, 10.1172/JCI78891 Allam, 2014, Immunological mechanisms of sublingual immunotherapy, Curr Opin Allergy Clin Immunol, 14, 564, 10.1097/ACI.0000000000000118 2001, Biomarkers and surrogate endpoints: preferred definitions and conceptual framework, Clin Pharmacol Ther, 69, 89, 10.1067/mcp.2001.113989 Taylor, 2008, Biomarkers in the assessment and management of airways diseases, Postgrad Med J, 84, 628, 10.1136/pgmj.2008.069864 Manolio, 2010, Genomewide association studies and assessment of the risk of disease, N Engl J Med, 363, 166, 10.1056/NEJMra0905980 Fitzpatrick, 2010, The molecular phenotype of severe asthma in children, J Allergy Clin Immunol, 125, 851, 10.1016/j.jaci.2010.01.048 Brasier, 2008, Molecular phenotyping of severe asthma using pattern recognition of bronchoalveolar lavage-derived cytokines, J Allergy Clin Immunol, 121, 30, 10.1016/j.jaci.2007.10.015 Anto, 2012, Understanding the complexity of IgE-related phenotypes from childhood to young adulthood: a Mechanisms of the Development of Allergy (MeDALL) seminar, J Allergy Clin Immunol, 129, 943, 10.1016/j.jaci.2012.01.047 Evaluation of Biomarkers and Surrogate Endpoints in Chronic Disease. Institutes of Medicines of the National Academies http://www.iomedu/Reports/2010/Evaluation-of-Biomarkers-and-Surrogate-Endpoints-in-Chronic-Diseaseaspx. 2010. Auffray, 2010, An integrative systems biology approach to understanding pulmonary diseases, Chest, 137, 1410, 10.1378/chest.09-1850 Bousquet, 2011, MeDALL (Mechanisms of the Development of ALLergy): an integrated approach from phenotypes to systems medicine, Allergy, 66, 596, 10.1111/j.1398-9995.2010.02534.x Westman, 2015, Early childhood IgE reactivity to pathogenesis-related class 10 proteins predicts allergic rhinitis in adolescence, J Allergy Clin Immunol, 135, 1199, 10.1016/j.jaci.2014.10.042 Willis, 2015, Immune biomarkers: the promises and pitfalls of personalized medicine, Nat Rev Immunol, 15, 323, 10.1038/nri3820 Campbell, 1998, Integrated care pathways, BMJ, 316, 133, 10.1136/bmj.316.7125.133 Integrated Care Pathways users in Scotland (ICPUS). A workbook for people starting to develop integrated care pathways. http://www.icpus.org.uk2007. Accessed May 2015 Bousquet, 2014, The European Innovation Partnership on Active and Healthy Ageing: the European Geriatric Medicine introduces the EIP on AHA Column, Eur Geriatr Med, 5, 361, 10.1016/j.eurger.2014.09.010 Bousquet, 2012, Severe chronic allergic (and related) diseases: a uniform approach--a MeDALL--GA2LEN--ARIA position paper, Int Arch Allergy Immunol, 158, 216, 10.1159/000332924 Bousquet, 2012, Allergic Rhinitis and its Impact on Asthma (ARIA): achievements in 10 years and future needs, J Allergy Clin Immunol, 130, 1049, 10.1016/j.jaci.2012.07.053 Morais-Almeida, 2013, Prevalence and classification of rhinitis in the elderly: a nationwide survey in Portugal, Allergy, 68, 1150 Morais-Almeida, 2013, Prevalence and classification of rhinitis in preschool children in Portugal: a nationwide study, Allergy, 68, 1278, 10.1111/all.12221 Klimek, 2015, Effectiveness of MP29-02 for the treatment of allergic rhinitis in real-life: results from a noninterventional study, Allergy Asthma Proc, 36, 40, 10.2500/aap.2015.36.3823 Bousquet, 2009, Unmet needs in severe chronic upper airway disease (SCUAD), J Allergy Clin Immunol, 124, 428, 10.1016/j.jaci.2009.06.027 Pfaar, 2014, Recommendations for the standardization of clinical outcomes used in allergen immunotherapy trials for allergic rhinoconjunctivitis: an EAACI Position Paper, Allergy, 69, 854, 10.1111/all.12383 Bousquet, 2010, Uncontrolled allergic rhinitis during treatment and its impact on quality of life: a cluster randomized trial, J Allergy Clin Immunol, 126, 666, 10.1016/j.jaci.2010.06.034 Demoly, 2013, Visual analogue scale in patients treated for allergic rhinitis: an observational prospective study in primary care: Asthma and Rhinitis, Clin Exp Immunol, 43, 881 Just, 2014, Natural history of allergic sensitization in infants with early-onset atopic dermatitis: results from ORCA Study, Pediatri Allergy Immunol, 25, 668, 10.1111/pai.12287 Just, 2014, Childhood allergic asthma is not a single phenotype, J Pediatr, 164, 815, 10.1016/j.jpeds.2013.11.037 Pinart, 2014, Comorbidity of eczema, rhinitis, and asthma in IgE-sensitised and non-IgE-sensitised children in MeDALL: a population-based cohort study, Lancet Respir Med, 2, 131, 10.1016/S2213-2600(13)70277-7 Hellings, 2013, Uncontrolled allergic rhinitis and chronic rhinosinusitis: where do we stand today?, Allergy, 68, 1, 10.1111/all.12040 Bousquet, 2013, Impact of Allergic Rhinitis Symptoms on Quality of Life in Primary Care, Int Arch Allergy Immunol, 160, 393, 10.1159/000342991 Sullivan, 2011, The burden of adult asthma in the United States: evidence from the Medical Expenditure Panel Survey, J Allergy Clin Immunol, 127, 363, 10.1016/j.jaci.2010.10.042 Sullivan, 2014, The relationship between asthma, asthma control and economic outcomes in the United States, J Asthma, 51, 769, 10.3109/02770903.2014.906607 Walker, 2007, Seasonal allergic rhinitis is associated with a detrimental effect on examination performance in United Kingdom teenagers: case–control study, J Allergy Clin Immunol, 120, 381, 10.1016/j.jaci.2007.03.034 Samolinski, 2012, Council of the European Union conclusions on chronic respiratory diseases in children, Lancet, 379, e45, 10.1016/S0140-6736(12)60514-5 Zuberbier, 2014, Economic burden of inadequate management of allergic diseases in the European Union: a GA(2) LEN review, Allergy, 69, 1275, 10.1111/all.12470 Masoli, 2004, The global burden of asthma: executive summary of the GINA Dissemination Committee Report, Allergy, 59, 469, 10.1111/j.1398-9995.2004.00526.x Asher, 2006, Worldwide time trends in the prevalence of symptoms of asthma, allergic rhinoconjunctivitis, and eczema in childhood: ISAAC Phases One and Three repeat multicountry cross-sectional surveys, Lancet, 368, 733, 10.1016/S0140-6736(06)69283-0 Pearce, 2007, Worldwide trends in the prevalence of asthma symptoms: Phase Three of the International Study of Asthma and Allergies in Childhood (ISAAC), Thorax, 62, 758, 10.1136/thx.2006.070169 Bousquet J, Khaltaev N. Global surveillance, prevention and control of Chronic Respiratory Diseases. A comprehensive approach. Global Alliance against Chronic Respiratory Diseases. World Health Organization. 2007:148. ISBN 978 92 4 156346 8. Gibson G, Loddenkemper R, Lundback B, Sibille Y. The new European Lung White Book: Respiratory health and disease in Europe: Geneve. ERS Publications; 2013. Gibson, 2013, Respiratory health and disease in Europe: the new European Lung White Book, Eur Respir J, 42, 559, 10.1183/09031936.00105513 Hankin, 2014, Allergy immunotherapy: what is the evidence for cost saving?, Curr Opin Allergy Immunol, 14, 363, 10.1097/ACI.0000000000000084 Creticos, 1996, Ragweed immunotherapy in adult asthma, N Engl J Med, 334, 501, 10.1056/NEJM199602223340804 Bousquet, 2011, How to design and evaluate randomized controlled trials in immunotherapy for allergic rhinitis: an ARIA-GA(2) LEN statement, Allergy, 66, 765, 10.1111/j.1398-9995.2011.02590.x Dranitsaris, 2014, Sublingual or subcutaneous immunotherapy for seasonal allergic rhinitis: an indirect analysis of efficacy, safety and cost, J Eval Clin Pract, 20, 225, 10.1111/jep.12112 Meadows, 2013, A systematic review and economic evaluation of subcutaneous and sublingual allergen immunotherapy in adults and children with seasonal allergic rhinitis, Health Technol Assess, 17, vi, 10.3310/hta17270 Barabasi, 2011, Network medicine: a network-based approach to human disease, Nat Rev Genet, 12, 56, 10.1038/nrg2918 Szepfalusi, 2014, Preventive sublingual immunotherapy in preschool children: First evidence for safety and pro-tolerogenic effects, Pediatr Allergy Immunol, 25, 788, 10.1111/pai.12310 Leynaert, 2000, Quality of life in allergic rhinitis and asthma. A population-based study of young adults, Am J Respir Crit Care Med, 162, 1391, 10.1164/ajrccm.162.4.9912033